IQX

iQXNSX:IQX Stock Report

Market Cap

AU$56.2m

7D

0%

1Y

n/a

Updated

25 Oct, 2021

Data

Company Financials
IQX fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

IQX Overview

IQX Limited is a venture capital firm, and fund manager focuses on early stage investments in Australian biotech and life science companies and other registered intellectual property.

Price History & Performance

Summary of all time highs, changes and price drops for iQX
Historical stock prices
Current Share PriceAU$0.13
52 Week HighAU$0.05
52 Week LowAU$0.14
Beta0.31
1 Month Change0%
3 Month Changen/a
1 Year Changen/a
3 Year Changen/a
5 Year Change-13.33%
Change since IPO73.34%

Recent News & Updates

Shareholder Returns

IQXAU Capital MarketsAU Market
7D0%2.3%0.8%
1Yn/a29.1%24.4%

Return vs Industry: Insufficient data to determine how IQX performed against the Australian Capital Markets industry.

Return vs Market: Insufficient data to determine how IQX performed against the Australian Market.

Price Volatility

Is IQX's price volatile compared to industry and market?
IQX volatility
IQX Beta0.31
Industry Beta0.99
Market Beta1

Stable Share Price: Insufficient data to determine IQX's volatility over the past 3 months.

Volatility Over Time: Insufficient data to determine IQX's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/an/aGeorge Syrmalishttps://www.iqxinvestments.com

IQX Limited is a venture capital firm, and fund manager focuses on early stage investments in Australian biotech and life science companies and other registered intellectual property. It typically invest post discovery before pre-clinical. The firm is based in Sydney, Australia with additional offices in Sydney, Australia; New York, New York; and Shanghai, China.

iQX Fundamentals Summary

How do iQX's earnings and revenue compare to its market cap?
IQX fundamental statistics
Market CapAU$56.18m
Earnings (TTM)-AU$23.13m
Revenue (TTM)AU$3.83m

14.7x

P/S Ratio

-2.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
IQX income statement (TTM)
RevenueAU$3.83m
Cost of RevenueAU$0
Gross ProfitAU$3.83m
ExpensesAU$26.96m
Earnings-AU$23.13m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-0.054
Gross Margin100.00%
Net Profit Margin-603.35%
Debt/Equity Ratio-53.3%

How did IQX perform over the long term?

See historical performance and comparison

Valuation

Is iQX undervalued compared to its fair value and its price relative to the market?


In this section, we usually try to help investors determine whether iQX is trading at an attractive price based on the cash flow it is expected to produce in the future. But as iQX has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Future Growth

How is iQX forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

9.0%

Forecasted Diversified Financials industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as iQX has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has iQX performed over the past 5 years?

-61.4%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: IQX is currently unprofitable.

Growing Profit Margin: IQX is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: IQX is unprofitable, and losses have increased over the past 5 years at a rate of 61.4% per year.

Accelerating Growth: Unable to compare IQX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: IQX is unprofitable, making it difficult to compare its past year earnings growth to the Capital Markets industry (12.8%).


Return on Equity

High ROE: IQX's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Financial Health

How is iQX's financial position?


Financial Position Analysis

Short Term Liabilities: IQX has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: IQX has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: IQX has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: IQX's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: IQX has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: IQX has less than a year of cash runway if free cash flow continues to reduce at historical rates of 4% each year


Dividend

What is iQX current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate IQX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate IQX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if IQX's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if IQX's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of IQX's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

8.2yrs

Average board tenure


CEO

George Syrmalis (55 yo)

6.92yrs

Tenure

AU$897,737

Compensation

Dr. George Syrmalis, M.D., Ph D., FACNP, MAAPP, has been Chief Executive Officer at FarmaForce Limited since November 24, 2015 and has been its Executive Director since November 24, 2015. He has been Chair...


CEO Compensation Analysis

Compensation vs Market: George's total compensation ($USD670.75K) is above average for companies of similar size in the Australian market ($USD302.38K).

Compensation vs Earnings: George's compensation has been consistent with company performance over the past year.


Board Members

Experienced Board: IQX's board of directors are considered experienced (8.2 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

iQX Limited's employee growth, exchange listings and data sources


Key Information

  • Name: iQX Limited
  • Ticker: IQX
  • Exchange: NSX
  • Founded: NaN
  • Industry: Asset Management and Custody Banks
  • Sector: Diversified Financials
  • Market Cap: AU$56.182m
  • Shares outstanding: 432.17m
  • Website: https://www.iqxinvestments.com

Location

  • iQX Limited
  • 85 Castlereagh Street
  • Level 9
  • Sydney
  • New South Wales
  • 2000
  • Australia

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/25 07:04
End of Day Share Price2021/08/10 00:00
Earnings2021/06/30
Annual Earnings2021/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.